-
1. Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in …
Link: https://ir.thermofisher.com/investors/news-events/news/news-details/2019/Thermo-Fisher-Scientific-to-Acquire-Brammer-Bio-a-Leader-in-Viral-Vector-Manufacturing-2019-3-24/default.aspx
Description: WEBMar 24, 2019 · Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies.
-
2. Brammer Bio | LinkedIn
Link: https://www.linkedin.com/company/brammer-bio-llc
Description: WEBAbout us. Brammer Bio is a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies...
-
3. Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in …
Link: https://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-acquire-brammer-bio-a-leader-in-viral-vector-manufacturing-300817478.html
Description: WEBMar 25, 2019 · About Brammer Bio. Brammer Bio provides clinical and commercial supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with process and analytical...
-
4. Thermo Fisher to Acquire Brammer Bio for $1.7B, Expanding …
Link: https://www.genengnews.com/news/thermo-fisher-to-acquire-brammer-bio-for-1-7b-expanding-gene-therapy-presence/
Description: WEBMarch 25, 2019. Thermo Fisher Scientific has agreed to acquire Brammer Bio for $1.7 billion cash, the companies said, in a deal designed to increase the buyer’s presence in gene therapy with...
-
5. Thermo Fisher Scientific Completes Acquisition of Brammer Bio
Link: https://ir.thermofisher.com/investors/news-events/news/news-details/2019/Thermo-Fisher-Scientific-Completes-Acquisition-of-Brammer-Bio-2019-5-1/default.aspx
Description: WEBMay 1, 2019 · SEC Filings. Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has completed its previously announced acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for approximately $1.7 billion in cash.
-
6. Thermo Fisher to buy Brammer Bio for $1.7B, expanding gene …
Link: https://www.biopharmadive.com/news/thermo-fisher-brammer-bio-gene-therapy-manufacturing-deal/551225/
Description: WEBMar 25, 2019 · Thermo Fisher Scientific will pay $1.7 billion in cash to buy Brammer Bio, a contract manufacturer of viral vectors, the companies said Sunday. Since forming in 2016 through the merger of two companies, Brammer has grown into a top CDMO for cell and gene therapy-focused biotechs, with nearly 600 employees. Thermo said the company is …
-
7. Brammer Bio, a Leader in Viral Vector Manufacturing, to be …
Link: https://biopharma-asia.com/sections/brammer-bio-a-leader-in-viral-vector-manufacturing-to-be-acquired-by-thermo-fisher-scientific/
Description: WEBMar 26, 2019 · Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies.
-
8. Thermo Fisher Scientific to Acquire Brammer Bio for $1.7 Billion
Link: https://ampersandcapital.com/thermo-fisher-scientific-to-acquire-brammer-bio-for-1-7-billion/
Description: WEBMar 25, 2019 · Brammer Bio is a leading viral vector contract development and manufacturing organization (CDMO), enabling biopharma customers to deliver breakthrough medicines to patients by unleashing the potential of gene therapies and gene-modified cell therapies.
-
9. Thermo Fisher Scientific Completes Acquisition of Brammer Bio
Link: https://www.prnewswire.com/news-releases/thermo-fisher-scientific-completes-acquisition-of-brammer-bio-300841447.html
Description: WEBMay 1, 2019 · Brammer Bio has nearly 600 employees at primary locations in Massachusetts and Florida and will become part of Thermo Fisher's Pharma Services business within its Laboratory Products and...
-
10. Brammer Bio announces progress on $200 million program to advance gene
Link: https://www.prnewswire.com/news-releases/brammer-bio-announces-progress-on-200-million-program-to-advance-gene-therapies-300719275.html
Description: WEBSep 26, 2018 · Brammer Bio provides clinical and commercial supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with process and analytical development, and regulatory ...